| Date | Description |
| 23 June 2009 | Vaccine Against Canine Flu Granted Conditional License by USDAROSELAND, N.J., June 23, 2009 – Intervet/Schering-Plough Animal Health, the global leader in veterinary biologicals, today announced the availability of the first vaccine against canine influenza virus ... |
| 17 June 2009 | Intervet/Schering-Plough Animal Health introduces NOBIVAC Lyme, a unique vaccine providing dogs with dual protectionROSELAND, N.J., June 15, 2009 – Intervet/Schering-Plough Animal Health announced the introduction of NOBIVAC Lyme. This new-generation Lyme vaccine is the only vaccine specifically designed to provide ... |
| 4 June 2009 | Intervet/Schering-Plough Animal Health continues to support the Afya Serengeti rabies project - Children join the fight to eradicate rabiesBOXMEER (The Netherlands), June 4, 2009 - Eradication of rabies remains firmly on the agenda for Intervet/Schering-Plough Animal Health as the company launches its latest campaign to support the Afya ... |
| 9 October 2008 | Intervet/Schering-Plough Animal Health extends its portfolio with LEVENTA® and supports veterinary endocrinologyBOXMEER (the Netherlands), October 9, 2008 – As the global leader in the field of veterinary endocrinology, Intervet/Schering-Plough Animal Health today announces a further extension to its portfolio ... |
| 20 August 2008 | Intervet/Schering-Plough Animal Health shows innovative portfolio at WSAVA congress, Dublin - Hubert Trentesaux appointed as head of Global Companion AnimalBOXMEER (the Netherlands), August 20, 2008 – At the 33rd annual World Small Animal Veterinary Association Congress (WSAVA) in Dublin, Ireland, August 20-24, Intervet/Schering-Plough Animal Health, presents ... |
| 27 February 2008 | Intervet takes the lead in veterinary endocrinology at NAVCORLANDO, FL, February 27, 2008 – As part of its global program to encourage continuing education and research in the field of veterinary internal medicine, Intervet International, a part of Schering-Plough, ... |
| 19 January 2008 | Schering-Plough & Intervet together for better careORLANDO, FL, January 19, 2008 –Throughout its history, Schering-Plough has focused on discovering and developing innovative new therapies in the human prescription, animal health and consumer health customer ... |
| 15 June 2006 | Free vaccine support for assistance dogsAssistance dogs fulfil a valuable role in society, greatly improving the quality of life enjoyed by their owners. Maintaining the health of these animals is crucial, but imposes additional financial burdens ... |
| 15 December 2005 | Reducing animal testingClostridial bacteria produce toxins that cause a range of diseases in animals. Vaccines against these diseases are often developed from the toxins themselves. The production of clostridial vaccines involves ... |
| 22 September 2005 | Schering-Plough Animal Health Lends Aid and Support to People and Pets Affected by HurricaneKatrina Disaster Underscores Importance of Animal IdentificationSchering-Plough Animal Health Corp. (SPAH) today announced that it has contributed nearly $130,000 to aid Hurricane Katrina relief efforts ... |
| 15 September 2005 | Intervet facilitates development of global small animal vaccination strategyIn September 2005, Intervet International organized the international symposium Canine and Feline vaccination – A scientific re-appraisal, in conjunction with the University of Utrecht’s Faculty of Veterinary ... |
| 25 June 2005 | Forging the Link campaign - Intervet UKIt is becoming increasingly recognized that family pets are being used as a tool to manipulate and control victims of domestic violence. Dad threatening to drown the kitten if little Tommy does not let ... |
| 25 June 2005 | Afya Serengeti project - Intervet UK‘Afya Serengeti’ means ‘Health for Serengeti’ in SwahiliHelping to control the incidence of animal and human rabies in north-western Tanzania is a key focus for Intervet UK this year and as such, the ... |
